Log in

OTCMKTS:ALTAAlterola Biotech Stock Price, Forecast & News

+1.22 (+6.17 %)
(As of 08/12/2020 04:00 PM ET)
Today's Range
Now: $21.00
50-Day Range
MA: $17.22
52-Week Range
Now: $21.00
Volume92,500 shs
Average Volume40,874 shs
Market Capitalization$394.55 million
P/E RatioN/A
Dividend Yield2.48%
Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Its products under development include appetite suppressors, cholesterol suppressors, antioxidant gums, motion sickness suppressors, and vitamin gums. The company was formerly known as Jedediah Resources Corp. and changed its name to Alterola Biotech, Inc. in July 2010. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech, Inc. is a subsidiary of London Pharma Holdings Limited.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.59 out of 5 stars

Industry, Sector and Symbol

Industry Conglomerates
Current SymbolOTCMKTS:ALTA



Sales & Book Value

Annual SalesN/A



Market Cap$394.55 million
Next Earnings DateN/A
OptionableNot Optionable
+1.22 (+6.17 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALTA News and Ratings via Email

Sign-up to receive the latest news and ratings for ALTA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Alterola Biotech (OTCMKTS:ALTA) Frequently Asked Questions

How has Alterola Biotech's stock price been impacted by COVID-19?

Alterola Biotech's stock was trading at $0.66 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ALTA shares have increased by 3,081.8% and is now trading at $21.00.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Alterola Biotech?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alterola Biotech in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Alterola Biotech

How were Alterola Biotech's earnings last quarter?

Alterola Biotech Inc (OTCMKTS:ALTA) issued its earnings results on Wednesday, July, 29th. The company reported $0.55 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.47 by $0.08. The business had revenue of $31.91 million for the quarter, compared to analysts' expectations of $30.39 million.
View Alterola Biotech's earnings history

How often does Alterola Biotech pay dividends? What is the dividend yield for Alterola Biotech?

Alterola Biotech declared a quarterly dividend on Friday, July 31st. Stockholders of record on Monday, August 10th will be paid a dividend of $0.13 per share on Monday, August 17th. This represents a $0.52 annualized dividend and a yield of 2.48%. The ex-dividend date of this dividend is Friday, August 7th.
View Alterola Biotech's dividend history

Has Alterola Biotech been receiving favorable news coverage?

Media coverage about ALTA stock has been trending extremely negative on Thursday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Alterola Biotech earned a news sentiment score of -4.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about Alterola Biotech

Who are some of Alterola Biotech's key competitors?

What other stocks do shareholders of Alterola Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alterola Biotech investors own include AbbVie (ABBV), Costco Wholesale (COST), Nucor (NUE), Roku (ROKU), Micron Technology (MU), NVIDIA (NVDA), Target (TGT), Accenture (ACN), Adobe (ADBE) and Analog Devices (ADI).

Who are Alterola Biotech's key executives?

Alterola Biotech's management team includes the following people:
  • Mr. Rene Lauritsen, Chief Operating Officer (Age 45)
  • Mr. Peter Maddocks, CEO, Pres, CFO, Principal Accounting Officer & Director (Age 60)

What is Alterola Biotech's stock symbol?

Alterola Biotech trades on the OTCMKTS under the ticker symbol "ALTA."

How do I buy shares of Alterola Biotech?

Shares of ALTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alterola Biotech's stock price today?

One share of ALTA stock can currently be purchased for approximately $21.00.

How big of a company is Alterola Biotech?

Alterola Biotech has a market capitalization of $394.55 million.

What is Alterola Biotech's official website?

The official website for Alterola Biotech is www.alterolabiotech.com.

How can I contact Alterola Biotech?

Alterola Biotech's mailing address is 228 Hamilton Ave Fl 3, PALO ALTO, CA 94301-2583, United States. The company can be reached via phone at +1-458-8429181.

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.